Charles Schwab’s Proterra Inc. Common Stock PTRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,322,831
Closed -$1.59M 3687
2023
Q2
$1.59M Sell
1,322,831
-190,605
-13% -$234K ﹤0.01% 2624
2023
Q1
$2.3M Buy
1,513,436
+4,694
+0.3% +$17.7K ﹤0.01% 2490
2022
Q4
$5.69M Buy
1,508,742
+37,372
+3% +$198K ﹤0.01% 2151
2022
Q3
$7.33M Buy
1,471,370
+60,003
+4% +$336K ﹤0.01% 2012
2022
Q2
$6.55M Buy
1,411,367
+488,565
+53% +$2.99M ﹤0.01% 2064
2022
Q1
$6.94M Buy
922,802
+24,259
+3% +$197K ﹤0.01% 2122
2021
Q4
$7.93M Buy
898,543
+37,466
+4% +$384K ﹤0.01% 2123
2021
Q3
$8.71M Buy
+861,077
New +$9.73M ﹤0.01% 2090

Other funds holding PTRA

Charles Schwab's PTRA Position: Q3 2023 in Review

Charles Schwab sold out of Proterra Inc. Common Stock (PTRA) in Q3 2023, closing a stake of 1,322,831 shares — an estimated $1.59M sold.

Charles Schwab first reported a position in PTRA in Q3 2021 and held it in 8 quarters. The position peaked at $8.71M in Q3 2021. 7 funds tracked by Wall St. Rank hold PTRA as of Q3 2023.

  • Charles Schwab reported no remaining Proterra Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Charles Schwab sold 1,322,831 Proterra Inc. Common Stock shares in Q3 2023, an estimated $1.59M.
  • Charles Schwab first reported a position in Proterra Inc. Common Stock in Q3 2021 and held it in 8 quarters.
  • Charles Schwab's Proterra Inc. Common Stock position peaked at $8.71M in Q3 2021.
  • 7 funds tracked by Wall St. Rank held Proterra Inc. Common Stock as of Q3 2023.

Based on Charles Schwab's 13F filing for Q3 2023, filed 8 Nov 2023.